These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1948725)

  • 1. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
    Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
    Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognosis of lupus nephritis during treatment with superhigh-dose cyclophosphane].
    Shilov EM; Krasnova TN; Ivanov AA; Akkuratova NV; Miroshnichenko NG; Gordovskaia NB; Tareeva IE
    Ter Arkh; 1992; 64(8):63-8. PubMed ID: 1440401
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N
    Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome].
    Kolesnik NA; Dudar' IA; Velichko MB
    Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
    Nazar PS
    Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment results in various morphological patterns of glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1984; 56(9):97-101. PubMed ID: 6515557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-morphological comparisons in patients with chronic glomerulonephritis and elevated arterial pressure].
    Gadaev AG; Akimova SL
    Urol Nefrol (Mosk); 1993; (5):33-6. PubMed ID: 8310582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Focal segmental glomerular hyalinosis: a special form of fibroplastic glomerulonephritis].
    Serov VV; Kupriianova LA; Varshavskiĭ VA; Pal'tsev MA; Nikolaev AIu
    Arkh Patol; 1982; 44(7):24-9. PubMed ID: 7125935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cyclophosphamide treatment of glomerulonephritis patients].
    Dorets'kyĭ VV
    Vrach Delo; 1991 Feb; (2):51-3. PubMed ID: 2058123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
    Rutkowski B; Wielgosz A; Manitius J; Bułło B; Kowalewska J; Tylicki L; Roszkiewicz A
    Przegl Lek; 2000; 57(11):624-7. PubMed ID: 11293209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclophosphamide efficacy in maintenance therapy of nephrotic syndrome in patients with chronic glomerulonephritis].
    Ter Arkh; 2004; 76(9):26-8. PubMed ID: 15532372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical trial of a new method for treating chronic nephritis with superhigh doses of cyclophosphane].
    Shilov EM; Krasnova TM; Ivanov AA; Tareeva IE
    Klin Med (Mosk); 1995; 73(3):86-90. PubMed ID: 8577125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.